Lexicon Pharmaceuticals (United States)

473 papers and 25.3k indexed citations i.

About

In recent decades, authors affiliated with Lexicon Pharmaceuticals (United States) have published 473 papers, which have received a total of 25.3k indexed citations. Scholars at this organization have produced 190 papers in Molecular Biology, 96 papers in Endocrinology, Diabetes and Metabolism and 57 papers in Surgery on the topics of Diabetes Treatment and Management (62 papers), Pancreatic Islet Dysfunction and Regeneration (45 papers) and Neuroendocrine Tumor Research Advances (36 papers). Their work is cited by papers focused on Molecular Biology (11.6k citations), Endocrinology, Diabetes and Metabolism (5.1k citations) and Surgery (3.4k citations). Authors at Lexicon Pharmaceuticals (United States) collaborate with scholars in United States, Germany and United Kingdom and have published in prestigious journals including Nature, Science and Cell. Some of Lexicon Pharmaceuticals (United States)'s most productive authors include Brian Zambrowicz, Arthur Sands, Kenneth A. Platt, Peter Vogel, Pablo Lapuerta, Flavio Villanustre, Taghi M. Khoshgoftaar, Edin Muharemagic, Naeem Seliya and Randall Wald.

In The Last Decade

Fields of papers published by authors at Lexicon Pharmaceuticals (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Lexicon Pharmaceuticals (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Lexicon Pharmaceuticals (United States) at the time of their publication.

Countries citing scholars working at Lexicon Pharmaceuticals (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Lexicon Pharmaceuticals (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Lexicon Pharmaceuticals (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lexicon Pharmaceuticals (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Breakdown of academic impact, for scholars at Burke Medical Research Institute Breakdown of academic impact, for scholars at Albany Molecular Research (United States) Breakdown of academic impact, for scholars at Toyota Technological Institute at Chicago Breakdown of academic impact, for scholars at Gesellschaft zur Förderung von Medizin-, Bio- und Umwelttechnologien Breakdown of academic impact, for scholars at Statistics Denmark Breakdown of academic impact, for scholars at Environmental Defense Fund Breakdown of academic impact, for scholars at INSEAD Breakdown of academic impact, for scholars at NASA Astrobiology Institute
Rankless by CCL
2025